APA (7th ed.) Citation

Takayuki Nemoto, Toshihiko Yanagita, Tasuku Kanai, & Akihiko Wada. (2009). Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: The Role of GSK-3β in the Maintenance of Steady-State Levels of Insulin Receptor Signaling Molecules and Nav1.7 Sodium Channel in Adrenal Chromaffin Cells. Elsevier.

Chicago Style (17th ed.) Citation

Takayuki Nemoto, Toshihiko Yanagita, Tasuku Kanai, and Akihiko Wada. Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: The Role of GSK-3β in the Maintenance of Steady-State Levels of Insulin Receptor Signaling Molecules and Nav1.7 Sodium Channel in Adrenal Chromaffin Cells. Elsevier, 2009.

MLA (9th ed.) Citation

Takayuki Nemoto, et al. Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: The Role of GSK-3β in the Maintenance of Steady-State Levels of Insulin Receptor Signaling Molecules and Nav1.7 Sodium Channel in Adrenal Chromaffin Cells. Elsevier, 2009.